Press Information Bureau
Government of India
PIB Headquarters
29 NOV 2021 6:13PM by PIB Delhi

  • 122.41 cr vaccine doses have been administered so far under Nationwide Vaccination Drive
  • Recovery Rate currently at 98.34%; Highest since March 2020
  • 9,905 recoveries in the last 24 hours increases Total Recoveries to 3,40,08,183
  • 8,309 new cases in the last 24 hours
  • India's Active caseload stands at 1,03,859; lowest in 544 days
  • Active cases account for less than 1% of total cases, currently at 0.30%; Lowest since March 2020
  • Daily positivity rate (1.09%) less than 2% for last 56 days
  • Weekly Positivity Rate (0.85%) less than 1% for last 15 days
  • 64.02 cr Total Tests conducted so far

       #Unite2FightCorona                                                                                    #IndiaFightsCorona









COVID-19 Update

India’s Cumulative COVID-19 Vaccination Coverage exceeds 122.41 Cr

More than 42.04 Lakh doses administered in the last 24 hours

Recovery Rate currently at 98.34%

8,309 New Cases reported in the last 24 hours

India's Active Case load stands at 1,03,859

Weekly Positivity Rate (0.85%) less than 1% for last 15 days


With the administration of 42,04,171 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 122.41 Cr (1,22,41,68,929) as per provisional reports till 7 am today. This has been achieved through 1,26,81,072 sessions.

The break-up of the cumulative figure as per the provisional report till 7 am today include:



1st Dose


2nd Dose




1st Dose


2nd Dose



Age Group 18-44 years

1st Dose


2nd Dose



Age Group 45-59 years

1st Dose


2nd Dose



Over 60 years

1st Dose


2nd Dose





The recovery of 9,905 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,40,08,183.

Consequently, India’s recovery rate stands at 98.34%.


Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 155 consecutive days now.

8,309 new cases were reported in the last 24 hours.


The Active Caseload presentlystands at 1,03,859. Active cases presently constitute 0.30% of the country's total Positive Cases, which is lowest since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 7,62,268tests being conducted. India has so far conducted over 64.02 Cr (64,02,91,325) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 0.85% remains less than 1% for the last 15 days now. The Daily Positivity rate reported to be1.09%. The daily Positivity rate has remained below2% for last 56 days and below 3% for 91 consecutive days now.

Update on COVID-19 Vaccine Availability in States/UTs
More than 137 Crore vaccine doses provided to States/UTs
More than 24.61 Crore balance and unutilized vaccine doses still available with States/UTs


The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccinemanufacturers in the country to States and UTs.




(As on 29 th  November 2021)






More than 137crore (1,37,01,65,070) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category.

More than 24.61 Cr (24,61,87,131) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.

Update on COVID-19

India issues Revised Guidelines for International Travelers in view of reported cases of new SARS-CoV-2 variant (Omicron) across the world

Guidelines require all travelers (irrespective of COVID-19 vaccination status) coming to India from countries identified as ‘countries at-risk’ to Mandatorily undergo post-arrival COVID-19 testing at Airport on Arrival


In continuation of the proactive and risk based approach for management of COVID-19 pandemic,Union Ministry of Health issuedrevised ‘Guidelines for International arrivals’ on 28th November, 2021. The updated guidelines require all travelers (irrespective of COVID-19 vaccination status) coming to India from countries identified as ‘countries at-risk’ to mandatorily undergo post-arrival COVID-19 testing at airporton arrival in addition to pre-departure COVID-19 testing undertaken 72 hours before the departure. For passengers found positive in these test, they will be isolated and treated as per the clinical management protocol besides their samples also taken for Whole Genome Sequencing. The passengers found negative can depart the airport but have to undergo home isolation for 7 days, followed by repeat testing on 8th day of arrival in India, followed by 7 days of self-monitoring.

Further, in view of reports of increasing number of countries reporting the Omicron variant, the present Guidelines also mandate that 5% of the travelers coming from countries which are not in the ‘at risk category’ will also be tested on random basis at the airports for COVID-19.

The B.1.1.529 variant (Omicron) was first reported to WHO from South Africa on 24 November 2021 and the WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) on 26th November 2021 has classified it as Variant of Concern (VoC) in view of large number mutations noted in the variant, some of which may make this mutation more transmissible and have immune escape behaviour. The emerging evidence on the issue is being monitored by Union Ministry of Health.

States have also been advised for rigorous surveillance of international passengers, enhanced testing, monitoring the hotspots of COVID -19, ensuring augmentation of health infrastructure, including undertaking samples for whole genome sequencing.